Dr. Gregory P. Kalemkerian is associate director of the Hematology/Oncology fellowship program at the University of Michigan Health System. Prior to assuming his post at the University of Michigan in 1999, Dr. Kalemkerian served in the role of a physician-scientist at Wayne State University’s Karmanos Cancer Institute’s lung cancer program located in Detroit. During his time there, from the years 1993-1999, Dr. Kalemkerian’s research centered upon the development of experimental therapies for lung cancer.
Board-certified in internal medicine and medical oncology, Dr. Kalemkerian’s clinical focus is in the area of thoracic oncology—lung cancer, mesothelioma, and thymoma. His research interests are centered on clinical trials that evaluate new treatments for these diseases. Dr. Kalemkerian is a member of the Small Cell Lung Cancer Guidelines Panel of the National Cancer Center Network and is the author of more than 50 research publications, editorials and review articles.
Main Speciality: Medical Oncology, Internal Medicine
Other Interests & Specialties: Lung cancer, lung therapies, thoracic oncology, lung cancer, mesothelioma, thymoma and the development of new treatments.
Certifications, Awards & Accolades: Board Certifications in Internal Medicine and Medical Oncology, Chairs the Small Cell Lung Cancer Guidelines Panel of the National Cancer Center Network, Receipt of the University of Michigan League of Clinical Excellence
Education & Experience:
- Medical School at Northwestern University Medical School
- Residency at Northwestern Memorial Hospital
- Fellowship at John Hopkins Hospital
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs